AUGUST 2023LIFE SCIENCES REVIEW4CONTENTSCONTENTSIN MY OPINION08Advanced Tissue Technologies Maximize Flexibility in Regenerative MedicineThomas Gilbert, Ph. D., Vice President, Research & Development, Integra LifesciencesLAST WORD30How CMOs/CDMOs can Add Value for Pharma CompaniesOzgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE:TAK]Thomas Philps, Founder12CO V ER S T O R YAccelerating Novel Enzyme Development with Neural NetworksAUG-MET BIOINFORMATICS
< Page 3 | Page 5 >